Alp Invest Partners B.V. Avrobio, Inc. Transaction History

Alp Invest Partners B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$10.08 - $27.21 $2.02 Million - $5.46 Million	-200,732 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$13.05 - $21.88 $561,750 - $941,846	-43,046 Reduced 17.66%	200,732 $4.04 Million
Q3 2019 Nov 13, 2019	BUY	$14.12 - $23.44 $1.3 Million - $2.16 Million	92,214 Added 60.84%	243,778 $3.44 Million
Q2 2019 Aug 13, 2019	BUY	$13.21 - $27.29 $2 Million - $4.14 Million	151,564 New	151,564 $2.46 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Alp Invest Partners B.V., based on Form 13F filings with the SEC.

Stay updated on Alp Invest Partners B.V. with notifications on news.